Phase 1 Refractory Glioblastoma Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

B7H3/IL13Ra2 Bispecific Armored Chimeric Antigen Receptor T-Cell Therapy Study for Recurrent/Refractory Glioblastoma

Recurrent GlioblastomaRefractory Glioblastoma

Second Affiliated Hospital, School of Medicine, Zhejiang University14 enrolled1 locationNCT07193628

Recruiting

Phase 1

IL13Ra2-CAR T Cells With or Without Nivolumab and Ipilimumab in Treating Patients With GBM

Recurrent GlioblastomaRefractory Glioblastoma

City of Hope Medical Center60 enrolled1 locationNCT04003649